BOOM
Recent additions may not be included but will usually appear in 24 hrs or less.
| Rational | Source |
|---|---|
|
Impact of probiotic Saccharomyces boulardii on the gut microbiome composition in HIV-treated patients: A double-blind, randomised, placebo-controlled trial. ✅
Go to Publication ✅
PloS one (PLoS One ) Vol: 12 Issue 4 Pages: e0173802 Pub: 2017 Epub: 2017 Apr 7 Authors Villar-García J , Güerri-Fernández R , Moya A , González A , Hernández JJ , Lerma E , Guelar A , Sorli L , Horcajada JP , Artacho A , D Auria G , Knobel H , |
|
|
Impact of probiotic Saccharomyces boulardii on the gut microbiome composition in HIV-treated patients: A double-blind, randomised, placebo-controlled trial. ✅
Go to Publication ✅
PloS one (PLoS One ) Vol: 12 Issue 4 Pages: e0173802 Pub: 2017 Epub: 2017 Apr 7 Authors Villar-García J , Güerri-Fernández R , Moya A , González A , Hernández JJ , Lerma E , Guelar A , Sorli L , Horcajada JP , Artacho A , D Auria G , Knobel H , |
|
|
Influence of dietary supplementation with Bacillus licheniformis and Saccharomyces cerevisiae as alternatives to monensin on growth performance, antioxidant, immunity, ruminal fermentation and microbial diversity of fattening lambs. ✅
Go to Publication ✅
Scientific reports (Sci Rep ) Vol: 8 Issue 1 Pages: 16712 Pub: 2018 Nov 12 Epub: 2018 Nov 12 Authors Jia P , Cui K , Ma T , Wan F , Wang W , Yang D , Wang Y , Guo B , Zhao L , Diao Q , |
|
|
Effect of live yeast Saccharomyces cerevisiae (Actisaf Sc 47) supplementation on the performance and hindgut microbiota composition of weanling pigs. ✅
Go to Publication ✅
Scientific reports (Sci Rep ) Vol: 8 Issue 1 Pages: 5315 Pub: 2018 Mar 28 Epub: 2018 Mar 28 Authors Kiros TG , Derakhshani H , Pinloche E , D`Inca R , Marshall J , Auclair E , Khafipour E , Van Kessel A , |
|
|
Effect of live yeast Saccharomyces cerevisiae (Actisaf Sc 47) supplementation on the performance and hindgut microbiota composition of weanling pigs. ✅
Go to Publication ✅
Scientific reports (Sci Rep ) Vol: 8 Issue 1 Pages: 5315 Pub: 2018 Mar 28 Epub: 2018 Mar 28 Authors Kiros TG , Derakhshani H , Pinloche E , D`Inca R , Marshall J , Auclair E , Khafipour E , Van Kessel A , |
|
|
Saccharomyces boulardii Administration Changes Gut Microbiota and Attenuates D-Galactosamine-Induced Liver Injury. ✅
Go to Publication ✅
Scientific reports (Sci Rep ) Vol: 7 Issue 1 Pages: 1359 Pub: 2017 May 2 Epub: 2017 May 2 Authors Yu L , Zhao XK , Cheng ML , Yang GZ , Wang B , Liu HJ , Hu YX , Zhu LL , Zhang S , Xiao ZW , Liu YM , Zhang BF , Mu M , |
|
|
Saccharomyces boulardii Administration Changes Gut Microbiota and Attenuates D-Galactosamine-Induced Liver Injury. ✅
Go to Publication ✅
Scientific reports (Sci Rep ) Vol: 7 Issue 1 Pages: 1359 Pub: 2017 May 2 Epub: 2017 May 2 Authors Yu L , Zhao XK , Cheng ML , Yang GZ , Wang B , Liu HJ , Hu YX , Zhu LL , Zhang S , Xiao ZW , Liu YM , Zhang BF , Mu M , |
|
|
Effect of Saccharomyces boulardii CNCM I-745 as complementary treatment of Helicobacter pylori infection on gut microbiome. ✅
Go to Publication ✅
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology (Eur J Clin Microbiol Infect Dis ) Vol: 39 Issue 7 Pages: 1365-1372 Pub: 2020 Jul Epub: 2020 Mar 3 Authors Cárdenas PA , Garcés D , Prado-Vivar B , Flores N , Fornasini M , Cohen H , Salvador I , Cargua O , Baldeón ME , |
|
|
Effects of a Saccharomyces cerevisiae fermentation product on fecal characteristics, metabolite concentrations, and microbiota populations of dogs subjected to exercise challenge. ✅
Journal of animal science (J Anim Sci ) Vol: Issue Pages: Pub: 2022 Dec 27 Epub: 2022 Dec 27 Authors Oba PM , Carroll MQ , Sieja KM , Nogueira JPS , Yang X , Epp TY , Warzecha CM , Varney JL , Fowler JW , Coon CN , Swanson KS , |
|
|
Saccharomyces boulardii Tht 500101 changes gut microbiota and ameliorates hyperglycaemia, dyslipidaemia, and liver inflammation in streptozotocin-diabetic mice. ✅
Go to Publication ✅
Beneficial microbes (Benef Microbes ) Vol: 10 Issue 8 Pages: 901-912 Pub: 2019 Dec 9 Epub: 2019 Dec 4 Authors Albuquerque RCMF , Brandão ABP , De Abreu ICME , Ferreira FG , Santos LB , Moreira LN , Taddei CR , Aimbire F , Cunha TS , |
|
|
Saccharomyces boulardii Tht 500101 changes gut microbiota and ameliorates hyperglycaemia, dyslipidaemia, and liver inflammation in streptozotocin-diabetic mice. ✅
Go to Publication ✅
Beneficial microbes (Benef Microbes ) Vol: 10 Issue 8 Pages: 901-912 Pub: 2019 Dec 9 Epub: 2019 Dec 4 Authors Albuquerque RCMF , Brandão ABP , De Abreu ICME , Ferreira FG , Santos LB , Moreira LN , Taddei CR , Aimbire F , Cunha TS , |
|
|
Comparison of the Effects of Enzymolysis Seaweed Powder and Saccharomyces boulardii on Intestinal Health and Microbiota Composition in Kittens. ✅
Go to Publication ✅
Metabolites (Metabolites ) Vol: 13 Issue 5 Pages: Pub: 2023 May 8 Epub: 2023 May 8 Authors Zhang M , Mo R , Li M , Qu Y , Wang H , Liu T , Liu P , Wu Y , |
|
|
Saccharomyces boulardii, a yeast probiotic, inhibits gut motility through upregulating intestinal serotonin transporter and modulating gut microbiota. ✅
Go to Publication ✅
Pharmacological research (Pharmacol Res ) Vol: 181 Issue Pages: 106291 Pub: 2022 Jul Epub: 2022 Jun 8 Authors Gu Y , Wang C , Qin X , Zhou B , Liu X , Liu T , Xie R , Liu J , Wang B , Cao H , |
|
|
Saccharomyces boulardii ameliorates gut dysbiosis associated cognitive decline. ✅
Go to Publication ✅
Physiology & behavior (Physiol Behav ) Vol: 236 Issue Pages: 113411 Pub: 2021 Jul 1 Epub: 2021 Mar 31 Authors Roy Sarkar S , Mitra Mazumder P , Chatterjee K , Sarkar A , Adhikary M , Mukhopadhyay K , Banerjee S , |
|
|
Effect of Saccharomyces boulardii and Bacillus subtilis B10 on gut microbiota modulation in broilers. ✅
Go to Publication ✅
Animal nutrition (Zhongguo xu mu shou yi xue hui) (Anim Nutr ) Vol: 4 Issue 4 Pages: 358-366 Pub: 2018 Dec Epub: 2018 Apr 3 Authors Qin C , Gong L , Zhang X , Wang Y , Wang Y , Wang B , Li Y , Li W , |
|
|
Effect of Saccharomyces boulardii and Mode of Delivery on the Early Development of the Gut Microbial Community in Preterm Infants. ✅
Go to Publication ✅
PloS one (PLoS One ) Vol: 11 Issue 2 Pages: e0150306 Pub: 2016 Epub: 2016 Feb 26 Authors Zeber-Lubecka N , Kulecka M , Ambrozkiewicz F , Paziewska A , Lechowicz M , Konopka E , Majewska U , Borszewska-Kornacka M , Mikula M , Cukrowska B , Ostrowski J , |
|
|
Effect of Saccharomyces boulardii and Mode of Delivery on the Early Development of the Gut Microbial Community in Preterm Infants. ✅
Go to Publication ✅
PloS one (PLoS One ) Vol: 11 Issue 2 Pages: e0150306 Pub: 2016 Epub: 2016 Feb 26 Authors Zeber-Lubecka N , Kulecka M , Ambrozkiewicz F , Paziewska A , Lechowicz M , Konopka E , Majewska U , Borszewska-Kornacka M , Mikula M , Cukrowska B , Ostrowski J , |
|
|
Effect of Saccharomyces boulardii on Liver Diseases: A Systematic Review. ✅
Go to Publication ✅
Microorganisms (Microorganisms ) Vol: 12 Issue 8 Pages: Pub: 2024 Aug 15 Epub: 2024 Aug 15 Authors Maslennikov R , Benuni N , Levshina A , Adzhieva F , Demina T , Kucher A , Pervushova E , Yuryeva E , Poluektova E , Zolnikova O , Kozlov E , Sigidaev A , Ivashkin V , |
|
|
The Effects of Dietary Saccharomyces cerevisiae Supplementation on Gut Microbiota Composition and Gut Health in Aged Labrador Retrievers. ✅
Go to Publication ✅
Animals : an open access journal from MDPI (Animals (Basel) ) Vol: 14 Issue 12 Pages: Pub: 2024 Jun 7 Epub: 2024 Jun 7 Authors Cui Y , Li D , Zhang M , Liu P , Wang H , Li Y , Wu Y , |
BOOM
All suggestions are computed solely on their predicted microbiome impact. Safety, side-effects etc must be evaluated by your medical professionals before starting. Some items suggests have significant risk of adverse consequences for some people.
Special thanks to David F Morrison and Geert Van Houcke for doing Quality Assurance. Special thanks to Oliver Luk, B.Sc. (Biology) from BiomeSight for spot checking the coding of data from the US National Library of Medicine
This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.
Copyright 2016-2023 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 § 1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.
